Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,529 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study in postmenopausal women with advanced or recurrent breast cancer (no. 2)--evaluation of efficacy and safety at the recommended clinical dose CGS20267 Study Group].
Kimijima I, Tominaga T, Nomizu T, Nomura Y, Takashima S, Koyama H, Sano M, Tohge T, Ueo H, Ikeda S, Ohashi Y; CGS20267 Study Group. Kimijima I, et al. Among authors: ikeda s. Gan To Kagaku Ryoho. 2002 May;29(5):741-9. Gan To Kagaku Ryoho. 2002. PMID: 12040678 Clinical Trial. Japanese.
[CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study for postmenopausal women with advanced or recurrent breast cancer (no. 1)--investigation of recommended clinical dose CGS20267 Study Group].
Abe R, Tominaga T, Nomizu T, Nomura Y, Takashima S, Koyama H, Sano M, Tohge T, Ueo H, Ikeda S, Ohashi Y; CGS20267 Study Group. Abe R, et al. Among authors: ikeda s. Gan To Kagaku Ryoho. 2002 May;29(5):729-40. Gan To Kagaku Ryoho. 2002. PMID: 12040677 Clinical Trial. Japanese.
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).
Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Chatani R, Shibata T, Nishimoto Y, Ogihara Y, Doi K, Oi M, Shiga T, Sueta D, Kim K, Tanabe Y, Koitabashi N, Takada T, Ikeda S, Nakagawa H, Tsukahara K, Shoji M, Sakamoto J, Hisatake S, Ogino Y, Fujita M, Nakanishi N, Dohke T, Hiramori S, Nawada R, Kaneda K, Ono K, Kimura T; ONCO PE Trial Investigators. Yamashita Y, et al. Among authors: ikeda s. Circulation. 2024 Nov 18. doi: 10.1161/CIRCULATIONAHA.124.072758. Online ahead of print. Circulation. 2024. PMID: 39556015
A multisite observational real-world study on the effectiveness of repetitive transcranial magnetic stimulation therapy for patients with treatment-resistant depression in Japan.
Matsuda Y, Kito S, Hiraki F, Izuno T, Yoshida K, Nakamura M, Kodaka F, Yamazaki R, Taruishi N, Imazu S, Kanazawa T, Mekata T, Moriyama S, Wada M, Nakajima S, Sawada K, Watanabe S, Takahashi S, Toi Y, Hayashi D, Igarashi S, Fujiyama K, Ikeda S, Tateishi H, Kojima R, Sato K, Boku S, Takebayashi M, Ogura M, Takaya A, Endo K, Kita A, Arai H, Kamimura H, Matsuo K, Denda K, Yamashiro S, Yoshioka D, Kizaki J, Mimura M, Noda Y. Matsuda Y, et al. Among authors: ikeda s. Psychiatry Res. 2024 Nov 10;342:116263. doi: 10.1016/j.psychres.2024.116263. Online ahead of print. Psychiatry Res. 2024. PMID: 39549597 Free article.
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2.
Takabayashi K, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Ono K, Kimura T; COMMAND VTE Registry-2 Investigators. Takabayashi K, et al. Among authors: ikeda s. J Intensive Care. 2024 Nov 5;12(1):45. doi: 10.1186/s40560-024-00755-x. J Intensive Care. 2024. PMID: 39497225 Free PMC article.
Initial anticoagulation therapy with single direct oral anticoagulant in patients with intermediate-high risk acute pulmonary embolism: From the COMMAND VTE Registry-2.
Shigeno R, Kim K, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Furukawa Y, Kimura T; COMMAND VTE Registry-2 Investigators. Shigeno R, et al. Among authors: ikeda s. Int J Cardiol. 2024 Oct 24;419:132680. doi: 10.1016/j.ijcard.2024.132680. Online ahead of print. Int J Cardiol. 2024. PMID: 39461566 No abstract available.
4,529 results